(Q41141203)

27 September 2017

1 reference

title

HIV vaccines: where we are and where we are going (English)

1 reference

27 September 2017

1

B F Haynes

1 reference

27 September 2017

language of work or name

English

0 references

publication date

1 October 1996

1 reference

27 September 2017

1 reference

27 September 2017

volume

348

1 reference

27 September 2017

issue

9032

1 reference

27 September 2017

page(s)

933-937

1 reference

Toward an understanding of the correlates of protective immunity to HIV infection

27 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2909339-7

7 January 2021

Keynote address: variations in the natural history of HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2909339-7

7 January 2021

Studies in subjects with long-term nonprogressive human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2909339-7

7 January 2021

Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2909339-7

7 January 2021

Major expansion of CD8+ T cells with a predominant V beta usage during the primary immune response to HIV.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2909339-7

7 January 2021

Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2909339-7

7 January 2021

The natural history of HIV-1 infection: virus load and virus phenotype independent determinants of clinical course?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2909339-7

7 January 2021

Replicative function and neutralization sensitivity of envelope glycoproteins from primary and T-cell line-passaged human immunodeficiency virus type 1 isolates.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2909339-7

7 January 2021

Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2909339-7

7 January 2021

Scientific and social issues of human immunodeficiency virus vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2909339-7

7 January 2021

HIV-specific cytotoxic T-cell activity in an HIV-exposed but uninfected infant

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2909339-7

7 January 2021

Clearance of HIV infection in a perinatally infected infant

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2909339-7

7 January 2021

HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2909339-7

7 January 2021

Antigenic oscillations and shifting immunodominance in HIV-1 infections.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2909339-7

7 January 2021

CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2909339-7

7 January 2021

HIV suppression by interleukin-16.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2909339-7

7 January 2021

Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2909339-7

7 January 2021

HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2909339-7

7 January 2021

Temporal analysis of the antibody response to HIV envelope protein in HIV-infected laboratory workers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2909339-7

7 January 2021

Predictors for non- and slow progression in human immunodeficiency virus (HIV) type 1 infection: low viral RNA copy numbers in serum and maintenance of high HIV-1 p24-specific but not V3-specific antibody levels

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2909339-7

7 January 2021

Maternal IgG1 and IgA antibody to V3 loop consensus sequence and maternal-infant HIV-1 transmission

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2909339-7

7 January 2021

Back to primary school

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2909339-7

7 January 2021

Viral dynamics in human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2909339-7

7 January 2021

Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2909339-7

7 January 2021

Recombination in AIDS viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2909339-7

7 January 2021

Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2909339-7

7 January 2021

Pathogenicity of live, attenuated SIV after mucosal infection of neonatal macaques

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2909339-7

7 January 2021

HIV type 1 V3 region primer-induced antibody suppression is overcome by administration of C4-V3 peptides as a polyvalent immunogen

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2909339-7

7 January 2021

Toward a vaccine for AIDS: the emergence of immunobiology-based vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2909339-7

7 January 2021

Natural protection against HIV-1 infection provided by HIV-2.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2909339-7

7 January 2021

Antibody production to the nucleocapsid and envelope of the hepatitis B virus primed by a single synthetic T cell site

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2909339-7

7 January 2021

10.1016/S0140-6736(96)09339-7

Identifiers

DOI

1 reference

27 September 2017

1 reference